Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01907659 · ClinicalTrials.gov registry record · NA
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT01907659 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 300 participants.
The verdict
NCT01907659, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
This trial is a pilot study to determine the feasibility of a randomized clinical trial comparing a treatment algorithm consisting of a limited number of clinical parameters, rapid molecular viral diagnostics, and serum procalcitonin testing to standard of care for directing antibiotic use in patients with non-pneumonic lower respiratory tract infection. The reduction in antibiotic use in those subjects randomized to the treatment algorithm compared to those randomized to standard care will be determined.
Interventions
- OTHER Release of test results
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01907659
The ClinicalTrials.gov registry entry for NCT01907659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Release of test results is the first listed.
NCT01907659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01907659 about?
NCT01907659 is a clinical study titled "Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections". This trial is a pilot study to determine the feasibility of a randomized clinical trial comparing a treatment algorithm consisting of a limited number of clinical parameters, rapid molecular viral diagnostics, and serum procalcitonin testing to standard of care for directing antibiotic use in patien...
What is the current status of trial NCT01907659?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2013-10. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01907659?
The interventions under investigation include: Release of test results (OTHER).
Who is sponsoring clinical trial NCT01907659?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.